Literature DB >> 17216084

Character of ocular surface mucins and their alteration in dry eye disease.

Ilene K Gipson1, Yuichi Hori, Pablo Argüeso.   

Abstract

At the ocular surface, three types of mucins are present. The large gel-forming mucin MUC5AC is expressed by conjunctival goblet cells. Some cells of the lacrimal gland acini express the small soluble mucin MUC7. The corneal and conjunctival epithelia express the membrane-associated mucins MUCs 1, 4, and 16. With the characterization of the mucin gene repertoire of the ocular surface epithelia, studies of the function of specific mucins, their gene regulation, and their alteration in ocular surface disease have begun. Current information suggests that all the mucins are hydrophilic and play a role in maintenance of water on the surface of the eye. The large secreted mucins represent the "janitorial service" that moves over the surface of the eye to wrap up and remove debris. The membrane-associated mucins form the glycocalyx, which provides a continuous barrier across the surface of the eye that prevents pathogen penetrance and has signaling capabilities that influence epithelial activity. Factors regulating mucin gene expression include retinoic acid, serum, and dexamethasone. Alteration in both secreted and membrane-associated mucins occur in drying ocular surface diseases. In Sjogren syndrome, MUC5AC expression is reduced, and in non-Sjogren dry eye, glycosylation of MUC16 appears to be altered. The pattern of expression of enzymes that glycosylate mucins is altered in ocular cicatricial pemphigoid. Therapies being evaluated for dry eye, including cyclosporine A, P2Y2 agonists, gefarnate, 15-(S)-HETE, and corticosteroids, may be efficacious due to their effect on mucin gene expression and secretion.

Entities:  

Year:  2004        PMID: 17216084     DOI: 10.1016/s1542-0124(12)70149-0

Source DB:  PubMed          Journal:  Ocul Surf        ISSN: 1542-0124            Impact factor:   5.033


  59 in total

1.  Diquafosol sodium ophthalmic solution for the treatment of dry eye: clinical evaluation and biochemical analysis of tear composition.

Authors:  Chika Shigeyasu; Masakazu Yamada; Yoko Akune; Kazuo Tsubota
Journal:  Jpn J Ophthalmol       Date:  2015-08-27       Impact factor: 2.447

2.  Antimicrobial defence mechanisms of the human parotid duct.

Authors:  H Kutta; J May; M Jaehne; A Münscher; F P Paulsen
Journal:  J Anat       Date:  2006-05       Impact factor: 2.610

Review 3.  The ocular surface: the challenge to enable and protect vision: the Friedenwald lecture.

Authors:  Ilene K Gipson
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-10       Impact factor: 4.799

Review 4.  Focus on Molecules: human mucin MUC16.

Authors:  Beatriz H Perez; Ilene K Gipson
Journal:  Exp Eye Res       Date:  2008-01-03       Impact factor: 3.467

5.  Exfoliative epitheliopathy of bullous keratopathy with breaches in the MUC16 Glycocalyx.

Authors:  Ben J Glasgow; Oktay K Gasymov; Richard C Casey
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-05-06       Impact factor: 4.799

6.  Interfacial interaction between transmembrane ocular mucins and adhesive polymers and dendrimers analyzed by surface plasmon resonance.

Authors:  I Bravo-Osuna; M Noiray; E Briand; A M Woodward; P Argüeso; I T Molina Martínez; R Herrero-Vanrell; G Ponchel
Journal:  Pharm Res       Date:  2012-05-08       Impact factor: 4.200

Review 7.  Current status of mucins in the diagnosis and therapy of cancer.

Authors:  Satyanarayana Rachagani; Maria P Torres; Nicolas Moniaux; Surinder K Batra
Journal:  Biofactors       Date:  2009 Nov-Dec       Impact factor: 6.113

8.  Role of cPKCalpha and nPKCepsilon in EGF-stimulated goblet cell proliferation.

Authors:  Marie A Shatos; Robin R Hodges; Yoshia Oshi; Jeffrey A Bair; Driss Zoukhri; Claire Kublin; Kameran Lashkari; Darlene A Dartt
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-09-29       Impact factor: 4.799

9.  The role of inflammation and antiinflammation therapies in keratoconjunctivitis sicca.

Authors:  Koray Gumus; Dwight H Cavanagh
Journal:  Clin Ophthalmol       Date:  2009-06-02

10.  Time course of ocular surface and lacrimal gland changes in a new scopolamine-induced dry eye model.

Authors:  Sabrina Viau; Marie-Annick Maire; Bruno Pasquis; Stéphane Grégoire; Cynthia Fourgeux; Niyazi Acar; Lionel Bretillon; Catherine P Creuzot-Garcher; Corinne Joffre
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-03-21       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.